EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Five Years of COVID-19 in Tocantins, Brazil: Epidemiology, Vaccination Impact, and SARS-CoV-2 Genomic Dynamics (2020–2025)

Olivia de Souza da Conceição, Ueric José Borges de Souza iD, Franciano Dias Pereira Cardoso iD, Evgeni Evgeniev Gabev iD, Bergmann Morais Ribeiro iD, Gil Rodrigues Dos Santos, Renisson Neponuceno de Araújo Filho, Marcos Gontijo da Silva iD, Fernando Rosado Spilki iD, Fabrício Souza Campos iD

Viruses · 2025

DOI: 10.3390/v17111521 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2025. Verfasst von Olivia de Souza da Conceição und 9 weiteren Autor:innen. Beteiligte Einrichtung: Bioinformatics and Biotechnology Laboratory, Campus of Gurupi, Federal University of Tocantins, Gurupi 77410-570, TO, Brazil. Hauptthemen laut MEDLINE: COVID-19, COVID-19 Vaccines, SARS-CoV-2, Evolution, Molecular. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Funding Authority for Studies and Projects, National Council for Scientific and Technological Development, Rede Corona-ômica BR MCTI/FINEP.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The coronavirus disease 2019 (COVID-19) pandemic in Tocantins, Brazil, exhibited distinct phases between 2020 and 2025, with high mortality concentrated in 2020–2021 and subsequent stabilization at residual levels. Using epidemiological data, statistical modeling, and genomic surveillance, we show that the crisis peaked in 2021, coinciding with the circulation of Gamma and Delta, when health system capacity was severely strained. From 2022 onwards, the spread of Omicron led to record incidence but proportionally low mortality, reflecting accumulated immunity, vaccination, and improved clinical management. Vaccination represented the turning point, reducing hospitalizations and deaths by over 90% and driving a clear decoupling between incidence and severity. Interrupted time-series and generalized additive model (GAM) analyses confirmed sustained reductions in transmission and severity associated with mass immunization. Genomic sequencing of 3941 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genomes identified 166 lineages and successive variant replacements, culminating in the predominance of LP.8.1.4 in 2025. To our knowledge, this is one of the few integrated, long-term analyses (2020–2025) combining epidemiological and genomic data, capturing the full succession of variants up to LP.8.1.4 and highlighting Tocantins as a strategic “variant corridor” linking Brazil’s North and Central-West regions. These findings underscore the dual role of vaccination and genomic surveillance in shaping the epidemic trajectory and the importance of sustaining both strategies to mitigate future health crises.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19COVID-19 VaccinesSARS-CoV-2Evolution, MolecularBrazilHumansInfantChild, PreschoolChildAdolescentYoung AdultAdultMiddle AgedAgedAged, 80 and overVaccinationGenome, ViralEpidemiological Monitoring

Stichwörter der Autor:innen

COVID-19SARS-CoV-2genomic surveillancevaccination impact

Substanzen

COVID-19 Vaccines

Autor:innen und Institutionen

  • Bioinformatics and Biotechnology Laboratory, Campus of Gurupi, Federal University of Tocantins, Gurupi 77410-570, TO, Brazil.
  • Central Public Health Laboratory of the State of Tocantins, Palmas 77054-970, TO, Brazil.
  • Department of Physiology and Pathophysiology, Medical University of Sofia, 1431 Sofia, Bulgaria.
  • Baculovirus Laboratory, Department of Cell Biology, Institute of Biological Sciences, University of Brasilia, Brasília 70910-900, DF, Brazil.
  • Laboratory of Phytopathology, Campus of Gurupi, Federal University of Tocantins, Gurupi 77402-970, TO, Brazil.
  • Departamento de Tecnologia Rural, Universidade Federal Rural de Pernambuco, Recife 52171-900, PE, Brazil.

ORCID-Profile: Ueric José Borges de Souza, Franciano Dias Pereira Cardoso, Evgeni Evgeniev Gabev, Bergmann Morais Ribeiro, Marcos Gontijo da Silva, Fernando Rosado Spilki, Fabrício Souza Campos

Förderung

  • Funding Authority for Studies and Projects
  • National Council for Scientific and Technological Development
  • Rede Corona-ômica BR MCTI/FINEP
  • Rede Vírus/MCTI

Zitieren

APA

Conceição, O. S. D., Souza, U. J. B., Cardoso, F. D. P., Gabev, E. E., Ribeiro, B. M., Santos, G. R. D., Araújo Filho, R. N., Silva, M. G. D., Spilki, F. R., & Campos, F. S. (2025). Five Years of COVID-19 in Tocantins, Brazil: Epidemiology, Vaccination Impact, and SARS-CoV-2 Genomic Dynamics (2020–2025). Viruses. https://doi.org/10.3390/v17111521

Vancouver

Conceição OSD, Souza UJB, Cardoso FDP, Gabev EE, Ribeiro BM, Santos GRD, et al. Five Years of COVID-19 in Tocantins, Brazil: Epidemiology, Vaccination Impact, and SARS-CoV-2 Genomic Dynamics (2020–2025). Viruses. 2025. doi:10.3390/v17111521

BibTeX
@article{Conceio2025,
  author = {Conceição, Olivia de Souza da and Souza, Ueric José Borges de and Cardoso, Franciano Dias Pereira and Gabev, Evgeni Evgeniev and Ribeiro, Bergmann Morais and Santos, Gil Rodrigues Dos and Araújo Filho, Renisson Neponuceno de and Silva, Marcos Gontijo da and Spilki, Fernando Rosado and Campos, Fabrício Souza},
  title = {Five Years of COVID-19 in Tocantins, Brazil: Epidemiology, Vaccination Impact, and SARS-CoV-2 Genomic Dynamics (2020–2025)},
  journal = {Viruses},
  year = {2025},
  doi = {10.3390/v17111521}
}
Kostenlos starten →